Compare GPMT & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | BEAT |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 23.9M |
| IPO Year | 2017 | 2021 |
| Metric | GPMT | BEAT |
|---|---|---|
| Price | $3.33 | $0.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $11.50 | $3.50 |
| AVG Volume (30 Days) | 43.1K | ★ 1.4M |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | ★ 10.72% | N/A |
| EPS Growth | ★ 73.58 | 15.07 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $308.40 | N/A |
| Revenue Next Year | $9.66 | $1,197.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.74 | $0.36 |
| 52 Week High | $7.61 | $4.00 |
| Indicator | GPMT | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 40.14 | 44.74 |
| Support Level | $1.39 | $0.38 |
| Resistance Level | $7.61 | $0.52 |
| Average True Range (ATR) | 0.34 | 0.05 |
| MACD | -0.28 | -0.01 |
| Stochastic Oscillator | 0.85 | 8.17 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.